Ranging from rare retinal dystrophies to common refractive errors, congenital ophthalmic diseases pose a significant challenge but also an opportunity for innovative therapeutic interventions. At Protheragen, our team of experienced biologists is dedicated to unraveling the complex molecular mechanisms of these debilitating diseases and providing expert therapy development services.